Medicine

All Articles

Prenatal exposure to destitution influences lifetime health

.Attributes Medicine, Released online: 09 September 2024 doi:10.1038/ d41591-024-00068-4Analysis of ...

A global metric of invulnerable health and wellness

.Nature Medicine, Published online: 05 September 2024 doi:10.1038/ s41591-024-03210-4A study uses '-...

Niacin, meals consumption and also heart results

.Attributes Medicine, Released online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, meal...

Opportunities and challenges for patient-reported outcome analysis in multimorbidity research and practice

.Competing interests.S.E.H. acquires financing from the National Institute of Wellness as well as Tr...

Hibernation science took advantage of to manage being overweight as well as tweak metabolic rate

.Attributes Medication, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy recognizi...

CAR- T and cellular genetics therapies are actually also expensive

.Nature Medication, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care pr...

The WHO genomics course of help nondiscriminatory execution of individual genomics for international health

.The magazine of the first draft of the human genome sequence in 20011 was observed due to the advan...

A time-stratified, case\u00e2 $ \"crossover study of heat energy direct exposure and also perinatal death from 16 healthcare facilities in sub-Saharan Africa

.One of 138,015 hospital-based singleton births in four sub-Saharan African nations, our team noted ...

Advancing global antibiotic analysis, development and also get access to #.\n\nMurray, C. J. L. et cetera. Global problem of microbial antimicrobial protection in 2019: an organized evaluation. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Leaders. In the direction of particular devotions and activity in the action to antimicrobial protection. Worldwide Leaders Team on Antimicrobial Resistance https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Planet Health And Wellness Company. That releases list of micro-organisms for which brand-new anti-biotics are actually quickly required. World Wellness Company https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Health And Wellness Organization. That microbial top priority pathogens list, 2024: bacterial pathogens of hygienics value to direct research study, advancement as well as methods to stop and handle antimicrobial protection. World Health Association https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt approach to Gram-negative entrance. Bioorg. Med. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Medication. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle.com Scholar\u00c2.\nWorld Health Organization. 2023 anti-bacterial brokers in clinical as well as preclinical advancement: an introduction and analysis. Planet Health Association https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Testimonial. May 19, 2016 \u00e2 $\" Addressing drug-resistant infections around the globe: ultimate record and also referrals. Review on Antimicrobial Protection https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB outputs: reports and rundown. Steer abdominal https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Breaking through the wall: an ask for concurrent action on antibiotics research and development. Boston ma Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Short 51: Exactly how can the EU support maintainable technology as well as accessibility to successful anti-biotics? policy alternatives for existing and also new medicines. International Observatory on Health And Wellness Equipments and also Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Antibiotic usage as well as resistance\u00e2 $\" showing the apparent. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Health And Wellness Organization. 2021 Conscious distinction. That get access to, view, get, classification of antibiotics for examination and surveillance of utilization. Planet Health Association https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). International Center for Illness Deterrence as well as Management. Antimicrobial resistance aim ats: just how can we reach all of them through 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Globe Wellness Company. Shortage of advancement readied to weaken antibiotic efficiency and also health and wellness gains. Planet Health Institution https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et al. Just how antimicrobial resistance is actually linked to weather change: a review of 2 entwined global challenges. Int. J. Environ. Res. Hygienics 20, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant microbial infections: our team require emergency action and expenditure that pay attention to the weakest link. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health And Wellness Association. Booster shot coverage. World Health and wellness Association https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Contamination protection and command in low-resource environments: the requirement for the local area, the contextual and the practical. Affect. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Problems of implementing antimicrobial conservation devices in low to center income countries (LMICs). Infect. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A short history of the antibiotic age: trainings found out and problems for the future. Face. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K. et cetera. Individual get access to in 14 high-income countries to brand new antibacterials permitted by the United States Fda, European Medicines Company, Japanese Pharmaceuticals and Medical Instruments Organization, or even Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Health And Wellness Company. 2021 anti-bacterial representatives in professional and also preclinical growth: an introduction as well as evaluation. Planet Wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Anti-biotics: the economics need to sustain the science. Attributes 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of development in antibacterial therapies. Medical Development Company https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Analyzing medical professional application of next-generation prescription antibiotics versus insusceptible Gram-negative infections in USA medical centers: a retrospective friend research. Ann. Trainee. Medication. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of innovation in antibacterial rehabs. Biotechnology Development Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A systematic review and essential analysis of motivation strategies for revelation as well as progression of novel antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nWellness Urgent Preparedness as well as Action Authority. R &amp d of clinical countermeasures. European Percentage https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). International Compensation. Pre-draft proposition for an European alliance under Horizon Europe One Health Antimicrobial Resistance. International Percentage https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Global Antibiotic Research and Development Collaboration. Entasis Therapeutics and the Worldwide Anti-biotic Investigation &amp Development Collaboration to create a new therapy for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of market- and non-industry-sponsored scientific trials. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Wellness Company. Variety of professional trial enrollments through place, disease, stage of progression, age and sex of trial participants (1999\u00e2 $ \"2022). Globe Health and wellness Organization https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Worldwide Antibiotic R &amp D Collaboration. NeoSept1: a research to determine the rank of existing and also brand new prescription antibiotics mixes to deal with newborns who remain in health center along with extreme blood poisoning. ISRCTN computer system registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Agency of Canada. Government of Canada creates important investment to eliminate antimicrobial resistance (AMR), Authorities of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). International Anti-biotic R &amp D Relationship. Japan authorities financing supports GARDP\u00e2 $ s attempts to respond to antibiotic protection. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 October 2023). Novo Nordisk Foundation. Novo Nordisk Structure partners with CARB-X to overcome drug-resistant infections. novo nordisk groundwork https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). European Commission: European Health as well as Digital Exec Company. Research study on bringing AMR medical countermeasures to the market place. Publications Workplace of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Estimating the proper size of worldwide pull motivations for anti-bacterial medications. Wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Sizing a market entrance incentive for the advancement of brand-new anti-biotics. Harvard Kennedy University https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Market rewards as well as antibiotic protection: an overview to the antibiotic vulnerability benefit. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An eager USG advanced commitment for subscription-based investing in of unfamiliar antimicrobials as well as its assumed return on investment. Center for Global Advancement https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 assets in new prescription antibiotics would certainly settle \u00e2 $\" for everyone. Workplace of Health Business economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS boosts war against deadly diseases adhering to effective world-first captain. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Process of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). European Payment. Reform of the EU pharmaceutical legalisation. European Compensation https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et al. Repayment models to tackle market breakdowns for antimicrobials: techniques enjoyed France, Germany, Sweden, the UK, and the USA. Health and wellness Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nInternational Alliance of Pharmaceutical Manufacturers and Affiliations. From protection to strength: what could the future antibiotic pipe look like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). International AMR R&ampD Center &amp Planet Health And Wellness Company. Incentivising the development of brand-new antibacterial procedures: 2023 report card due to the International AMR R&ampD Hub and also WHO. Global AMR R&ampD Center https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Singer, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK registration design for antibiotics thought about effective? Lancet Germ 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNon-paper \u00e2 $\" unique stimulations for the development and also going on the market place of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, local, and nationwide root causes of kid mortality in 2000\u00e2 $ \"13, with forecasts to update post-2015 concerns: an improved methodical analysis. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et cetera. Antibacterial medication lacks coming from 2001 to 2013: ramifications for medical practice. Clin. Corrupt. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nBenhabib, A. et cetera. The French reporting unit for medicine scarcities: summary as well as trends coming from 2012 to 2018: an empirical retrospective research study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et cetera. Analysis of that antibiotic consumption and gain access to targets in 76 nations, 2000\u00e2 $ \"15: a study of pharmaceutical purchases data. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Fighting the fakes: dealing with low quality as well as falsified medications. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it receiving much easier to secure antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrican Community for Lab Medicine. Plan brief and infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et al. National antibiotic consumption for human usage in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional research study. Trop. Medication. Infect. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nNamugambe, J. S. et cetera. National antimicrobial consumption: evaluation of core warehouses materials to in-patient care health facilities from 2017 to 2019 in Uganda. Trop. Med. Corrupt. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et cetera. Variations in the usage of antimicrobial medicines in the International area, 2014\u00e2 $ \"2018: seekings as well as ramifications coming from ESAC-Net as well as WHO Europe. Front end. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nShukar, S. et cetera. Medication lack: sources, impact, and mitigation tactics. Front. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Patient gain access to in 14 high-income nations to new antibacterials approved due to the US Fda, European Medicines Agency, Japanese Pharmaceuticals as well as Medical Instruments Organization, or Health Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPulcini, C. et cetera. Forgotten anti-biotics: a follow-up inventory research in Europe, the U.S.A., Canada and also Australia. Int. J. Antimicrob. Representatives 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health and wellness development for global wellness. Br. Med. J. 366, 15601 (2019 ).\nGoogle.com Scholar\u00c2.\nAMR Sector Partnership. The 2023 AMR Market Partnership progress study: manufacturing and the atmosphere. amr Industry Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Venture, D. &amp Gaule, P. Can health care products be cultivated on a charitable manner? Looking into product progression relationships for forgotten health conditions. Sci. Public law 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nSwaminathan, S. et cetera. Reboot biomedical R&ampD in the global public enthusiasm. Attributes 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrica Centres for Condition Control and Protection. Africa CDC leads bold transfer to secure Africa\u00e2 $ s wellness future by making a 50 billion buck health care market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Gore, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Haggling public-health trademark licensing agreements to improve accessibility to health modern technologies: an insider\u00e2 $ s tale. BMJ Glob. Health 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New company models for experimentation with price criteria are actually needed to have to achieve fair pricing of medicines. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Bacteria Biopharmaceutical Gas. Conservation and get access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Worldwide Anti-biotic R &amp D Relationship. Shinogi, GARDP as well as CHAI reveal spots permit as well as collaboration arrangements to deal with bacterial diseases by broadening access to cefiderocol in 135 countries. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Industry Collaboration. Leaving behind the laboratory: tracking the decrease in AMR R&ampD professionals. amr Business Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Wellness Ministers. G7 Health And Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 call to action on antimicrobial protection. G7G20 Documentations Database https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). International Union on Aging &amp Infectious Ailments Community of United States. 2024 AMR readiness index progress report. Gauging federal government action on AMR plan. Global Union on Aging https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Meals and Agriculture Company of the United Nations, United Nations Environment Program, Planet Wellness Organization &amp. World Organisation for Creature Wellness. Worldwide database for tracking antimicrobial resistance (AMR): country self-assessment survey (TrACSS). WHO https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Truck Katwyk, S. R. &amp Outterson K. Overview: AMR belongs in the as...

Integrating liver endpoints in professional trials of cardiovascular and kidney condition

.Nature Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective r...